Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:20 PM
Ignite Modification Date:
2025-12-24 @ 12:20 PM
NCT ID:
NCT02324361
Eligibility Criteria:
Inclusion Criteria:
* Index child's BMI ≥90th percentile
* Index child age between 3 and 7 years of age at time of enrollment in study
* The child is under the care of a primary care provider at the Quincy Pediatric Associates practice
* The family is not planning to move from the Greater Boston area during the study period
The participating parent/guardian:
* Is 18 years or older
* Is the primary caregiver for the child
* Has regular access to the Internet
* Has regular access to a personal computer with USB connection OR a smartphone with a mobile operating system that is compatible with the physical activity tracker
* Owns a Facebook account AND a cellphone with text messaging capability and if choosing the text-messaging intervention, is willing to receive a maximum of 62 text messages/month for 3 months on their personal cellphone
* Is fluent in English (spoken and written)
Exclusion Criteria:
* Children who are diagnosed with underlying medical or pharmacologic factors that may contribute to obesity and/or affect participation in physical activity
* Significant medical or psychiatric co-morbidities in the participating parent/guardian
* Visual, hearing, or cognitive impairments in the participating parent/guardian
* Index child or parent/guardian currently enrolled in another weight control program
* Children who have a sibling already enrolled in the study
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
3 Years
Maximum Age:
7 Years
Study:
NCT02324361
Study Brief:
Protocol Section:
NCT02324361